ICUI
ICU Medical, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow +9.9% ·
net new positions -18.2%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +1 | 16.65M | $2.44B | +7 | −7 |
| Q1 2026 | 104 | -4 | 18.58M | $2.40B | +5 | −10 |
| Q4 2025 | 108 | +2 | 19.90M | $2.83B | +3 | — |
| Q3 2025 | 19 | +2 | 11.89M | $1.43B | +3 | −2 |
| Q2 2025 | 15 | -1 | 9.62M | $1.27B | — | −1 |
| Q1 2025 | 13 | +1 | 2.74M | $379.97M | +2 | −1 |
| Q4 2024 | 12 | 0 | 3.47M | $538.76M | — | — |
| Q3 2024 | 11 | -2 | 3.16M | $575.79M | — | −2 |
| Q2 2024 | 13 | — | 2.88M | $341.58M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 937.50K | -35.0% | $170.83M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 2 | Citadel Advisors ✦ | 653.34K | +217.4% | $119.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 546.95K | +9.6% | $99.69M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 538.11K | +295.5% | $98.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 248.86K | +21.6% | $45.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 150.31K | -46.7% | $27.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Gotham Asset Management ✦ | 33.20K | +92.6% | $6.05M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | GAMCO Investors ✦ | 25.34K | -6.3% | $4.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 15.19K | +8.3% | $2.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 7.51K | -73.8% | $1.37M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 11 | Bridgewater Associates ✦ | 3.46K | -8.6% | $631,210 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Renaissance Technologies | $1.19M | was 0.0% |
| Marshall Wace | $670,581 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 273 holders, 24.54M shares, $3.09B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 724 sh · $122,736
Officer · 2.20K sh · $369,203
Officer · 1.24K sh · $208,523
Officer · 692 sh · $118,688
Officer · 6.38K sh · $1.12M
Officer · 4.57K sh · $792,291
Officer · 1.71K sh · $292,843
Officer · 1.91K sh · $329,443
Officer · 1.11K sh · $193,567
Officer · 5.42K sh · $982,265
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology